系统性红斑狼疮患者 COVID-19 疫苗接种后与眼部不良事件的时间关联：病例报告。
An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report.
机构信息
College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
出版信息
Hum Vaccin Immunother. 2021 Nov 2;17(11):4102-4104. doi: 10.1080/21645515.2021.1976036. Epub 2021 Oct 7.
Abstract
After the COVID-19 pandemic, vaccines using inactivated viruses have attracted worldwide attention for the prevention of infectious diseases. Here, we report a patient who suffered from Systemic Lupus Erythematosus (SLE) for six years and developed ocular symptoms within 72 hours after being vaccinated for COVID-19. The patient presented bilateral conjunctival congestion, eyelid edema with pruritus, and suffered from severe headaches. Recovery occurred within 10 days after the onset of symptoms after treatment with anti-infection drugs. The early identification and extensive assessment of side effects help ensuring effective vaccine safety monitoring.
摘要
在 COVID-19 大流行之后，用于预防传染病的灭活病毒疫苗引起了全球关注。在这里，我们报告了一位患有系统性红斑狼疮 (SLE) 六年的患者，在接种 COVID-19 疫苗后 72 小时内出现眼部症状。患者表现为双眼结膜充血、眼睑水肿伴瘙痒，并伴有严重头痛。在开始出现症状后 10 天内，经抗感染药物治疗后症状缓解。早期识别和广泛评估副作用有助于确保有效的疫苗安全性监测。
相似文献
1
An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report.系统性红斑狼疮患者 COVID-19 疫苗接种后与眼部不良事件的时间关联：病例报告。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4102-4104. doi: 10.1080/21645515.2021.1976036. Epub 2021 Oct 7.
2
Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.188 例系统性红斑狼疮患者对新型冠状病毒灭活疫苗的态度及其安全性：一项疫苗接种后横断面调查。
Clin Exp Med. 2023 Jun;23(2):457-463. doi: 10.1007/s10238-022-00832-1. Epub 2022 May 25.
3
Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination.接种 SARS-CoV-2 疫苗后新发系统性红斑狼疮的临床特征。
Mod Rheumatol Case Rep. 2023 Dec 29;8(1):63-68. doi: 10.1093/mrcr/rxad036.
4
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.系统性红斑狼疮患者接种 SARS-CoV-2 疫苗后的副作用和 flares 风险。
Clin Rheumatol. 2022 May;41(5):1349-1357. doi: 10.1007/s10067-021-05980-5. Epub 2021 Nov 16.
5
Systemic Lupus Erythematosus and COVID-19.系统性红斑狼疮与 COVID-19。
Curr Rheumatol Rep. 2023 Oct;25(10):192-203. doi: 10.1007/s11926-023-01110-z. Epub 2023 Jul 21.
6
Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report.接种 COVID-19 疫苗后出现系统性红斑狼疮和抗磷脂综合征。病例报告。
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):43-46. doi: 10.1093/mrcr/rxac018.
7
Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus.SARS-CoV-2 mRNA 疫苗对系统性红斑狼疮患者疾病活动度的中期影响。
Lupus Sci Med. 2022 Aug;9(1). doi: 10.1136/lupus-2022-000727.
8
Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.COVID-19 大流行下的系统性红斑狼疮：感染、疫苗接种及其对疾病管理的影响。
Clin Rheumatol. 2022 Sep;41(9):2893-2910. doi: 10.1007/s10067-022-06227-7. Epub 2022 May 31.
9
Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.在系统性红斑狼疮患者中使用异源加强针后，康希诺新冠疫苗的免疫原性、安全性和反应原性：一项病例系列研究。
RMD Open. 2021 Dec;7(3). doi: 10.1136/rmdopen-2021-002019.
10
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗（灭活，Vero 细胞）有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
引用本文的文献
1
Tubulointerstitial nephritis and uveitis syndrome (TINU) following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后出现的肾小管间质性肾炎和葡萄膜炎综合征（TINU）
Am J Ophthalmol Case Rep. 2023 Sep;31:101869. doi: 10.1016/j.ajoc.2023.101869. Epub 2023 Jun 10.
2
The Implications of SARS-CoV-2 Infection in a Series of Neuro-Ophthalmological Manifestations-Case Series and Literature Review.新型冠状病毒2感染在一系列神经眼科表现中的影响——病例系列及文献综述
J Clin Med. 2023 May 31;12(11):3795. doi: 10.3390/jcm12113795.
3
Ocular adverse effects of COVID-19 vaccines: A systematic review.新冠疫苗的眼部不良反应：一项系统综述。
J Family Med Prim Care. 2022 Sep;11(9):5041-5054. doi: 10.4103/jfmpc.jfmpc_747_22. Epub 2022 Oct 14.
4
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
本文引用的文献
1
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.中国医护人员中灭活 SARS-CoV-2 疫苗的安全性。
Expert Rev Vaccines. 2021 Jul;20(7):891-898. doi: 10.1080/14760584.2021.1925112. Epub 2021 May 13.
2
Ocular adverse events following vaccination: overview and update.接种疫苗后的眼部不良事件：概述和更新。
Surv Ophthalmol. 2022 Mar-Apr;67(2):293-306. doi: 10.1016/j.survophthal.2021.04.001. Epub 2021 Apr 16.
3
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.评价由科兴中维生产的新型冠状病毒（灭活）疫苗对医护人员的有效性和安全性的双盲、随机、安慰剂对照 III 期临床试验 - PROFISCOV：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 15;21(1):853. doi: 10.1186/s13063-020-04775-4.
4
Exploration of vascular adhesion protein-1 expression in patients with conjunctivitis associated systemic lupus erythematosus using 2D-DIGE.利用二维差异凝胶电泳技术探索血管黏附蛋白-1在伴有系统性红斑狼疮的结膜炎患者中的表达情况。
Exp Ther Med. 2019 Dec;18(6):5072-5077. doi: 10.3892/etm.2019.8009. Epub 2019 Sep 16.
5
Update: Vaccines in primary immunodeficiency.更新：原发性免疫缺陷病中的疫苗。
J Allergy Clin Immunol. 2018 Feb;141(2):474-481. doi: 10.1016/j.jaci.2017.12.980. Epub 2017 Dec 27.
6
Acute Bilateral Photoreceptor Degeneration in an Infant After Vaccination Against Measles and Rubella.婴儿接种麻疹和风疹疫苗后发生急性双侧光感受器变性
JAMA Ophthalmol. 2017 May 1;135(5):478-482. doi: 10.1001/jamaophthalmol.2017.0380.
7
Ocular manifestations in systemic lupus erythematosus.系统性红斑狼疮的眼部表现
Br J Ophthalmol. 2016 Jan;100(1):135-41. doi: 10.1136/bjophthalmol-2015-306629. Epub 2015 Apr 22.
8
Systemic lupus erythematosus disease activity index 2000.2000年系统性红斑狼疮疾病活动指数
J Rheumatol. 2002 Feb;29(2):288-91.
Zotero 插件